| NEA | NMI | NEA / NMI | |
| Gain YTD | 8.709 | 10.693 | 81% |
| Net Assets | 3.53B | 110M | 3,213% |
| Total Expense Ratio | 1.41 | 0.72 | 196% |
| Turnover | 12.00 | 38.00 | 32% |
| Yield | 4.50 | 4.60 | 98% |
| Fund Existence | 23 years | 38 years | - |
| NEA | NMI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 53% | 2 days ago 73% |
| Stochastic ODDS (%) | 2 days ago 65% | 2 days ago 86% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 81% |
| MACD ODDS (%) | 2 days ago 66% | 2 days ago 78% |
| TrendWeek ODDS (%) | 2 days ago 69% | 2 days ago 72% |
| TrendMonth ODDS (%) | 2 days ago 72% | 2 days ago 84% |
| Advances ODDS (%) | 4 days ago 73% | 4 days ago 82% |
| Declines ODDS (%) | 2 days ago 75% | N/A |
| BollingerBands ODDS (%) | 2 days ago 68% | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 62% | 2 days ago 78% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBTTX | 33.84 | N/A | N/A |
| Fidelity Advisor Biotechnology M | |||
| DGOCX | 27.91 | -0.38 | -1.34% |
| Davis Opportunity C | |||
| GEMWX | 14.82 | -0.22 | -1.46% |
| Goldman Sachs Emerging Mkt Eq ex. Chn R6 | |||
| ASLGX | 145.38 | -3.23 | -2.17% |
| American Century Select R5 | |||
| MISCX | 19.57 | -0.55 | -2.73% |
| BNY Mellon Small Cap Multi-Strategy Inv | |||
A.I.dvisor tells us that NEA and NIQ have been poorly correlated (+-5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NEA and NIQ's prices will move in lockstep.